When the EU’s Innovative Medicines Initiative launched the five-year EHDEN project in November 2018, it did so with an overarching goal in mind: to significantly improve patient treatment and care by unlocking the under-utilised and transformational potential of real world data. To this end, EHDEN began its journey to provide a new paradigm for the … Read more
While there was extensive use of drug repurposing throughout the first 10 months of the COVID-19 pandemic, there was substantial heterogeneity over the types of drugs used for treatment purposes globally. Some drugs, including hydroxychloroquine, saw sharp declines in use, while adjunctive therapies grew into a more relied upon method for patient management. In a … Read more
22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data & Evidence Network (EHDEN) is delighted to announce its involvement in establishing a European framework and research network for the conduct of multicentre cohort studies on the use of medicines in COVID-19 patients. The European Medicines Agency (EMA) has announced a … Read more
15 June, 2020, Brussels, Belgium: From 16 April – 14 May, EHDEN announced a rolling COVID-19 Rapid Collaboration Call. Its goal is to help clinicians, scientists, governments and the public to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. Upon conclusion of … Read more
19 May, 2020, Brussels, Belgium: Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. To help provide these answers, EHDEN announced a rolling COVID-19 Rapid Collaboration Call, which ran from 16 April – 14 … Read more
IMI2 Project European Health Data & Evidence Network (EHDEN) Starts its five-year programme